Sign in
Stories
Securities Class Actions Amid Allegations
Share
Assertio Holdings Faces Securities Law I...
Startup Funding and Lawsuits in Travel a...
AlloVir Class Action Lawsuit Filed
Altimmune Faces Investor Investigation
Amylyx Pharmaceuticals Faces Lawsuit
Overview
API
Several companies including BioNTech SE, Mobileye Global Inc., BioVie Inc., and Archer-Daniels-Midland Company are facing class action lawsuits for alleged misleading statements and improper practices. Notably, Archer-Daniels-Midland Company is accused of inaccurate growth reporting. Meanwhile, Kirby McInerney LLP reminds investors of a class action against Amylyx Pharmaceuticals, Inc. for purported misleading statements regarding RELYVRIO.
Ask a question
How might these class actions impact investor confidence in the companies and the broader market?
What implications do these legal battles have for the future operations and reputation of the companies involved?
What measures should companies take to ensure transparency and compliance with securities laws to avoid such legal challenges?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Dec 2023
Jan 2024
Feb 2024
Mar 2024
Coverage